BIRAN, Valérie |
| Active, not recruiting | 2/3 | 824 | Europe | Acetaminophen, NACL 0.9% | Institut National de la Santé Et de la Recherche Médicale, France, UPCET, PARTNERS for International clinical Research, European Fundation for the Care of the Newborn Infants, Connect for Children | Patency of the Ductus Arteriosus, Acetaminophen, Extreme Prematurity | 07/24 | 07/24 | | |
| Active, not recruiting | N/A | 48 | Europe | Crawling stimulation with the crawliskate, Tummy time without the crawliskate | Marianne Barbu-Roth, Ecole Pratique des Hautes Etudes | Prematurity | 11/21 | 11/24 | | |
| Recruiting | N/A | 5000 | Europe | hospitalized children with Covid19 | Centre Hospitalier Intercommunal Creteil, Association Clinique Thérapeutique Infantile du val de Marne, GPIP, Société Française de Pédiatrie, Francophone Pediatric Resuscitation and Emergency Group (GFRUP) | COVID-19 | 06/24 | 06/24 | | |
Volem, NCT06334523: Ventilation of the Extremely Premature Infants Optimized by Dead Space Washout |
|
|
| Not yet recruiting | N/A | 144 | NA | ventilation, Continuous Tracheal Gas Insufflation | Centre Hospitalier Intercommunal Creteil | Extremely Low Birthweight Infant, Continuous Tracheal Gas Insufflation, Medical Device, Lung Protection, Ventilator-Induced Lung Injury | 12/26 | 12/27 | | |
Premalocom2, NCT06027645: Early Intervention Based on Neonatal Crawling in Very Premature Infants at Risk For Neurodevelopmental Disorder |
|
|
| Recruiting | N/A | 50 | Europe | Crawling stimulation with a mini-skateboard (i.e. the crawliskate) | Marianne Barbu-Roth, Ecole Pratique des Hautes Etudes, Université Paris Cité, San Francisco State University, Assistance Publique - Hôpitaux de Paris | Prematurity, Extreme Prematurity, Infant Development, Brain Damage, Motor and Developmental Delay | 12/25 | 12/29 | | |
| Recruiting | N/A | 500 | Europe | 2 year follow-up of neurodevelopment using a parental questionnaire | Institut National de la Santé Et de la Recherche Médicale, France | Patency of the Ductus Arteriosus Acetaminophen Extreme Prematurity | 12/26 | 06/27 | | |
Sarret, Catherine |
| Recruiting | 3 | 300 | Europe, Japan, US, RoW | Galcanezumab, LY2951742, Placebo | Eli Lilly and Company | Chronic Migraine | 07/25 | 03/26 | | |
| Recruiting | 3 | 1633 | Europe, Japan, US, RoW | Lasmiditan, LY573144, Placebo | Eli Lilly and Company | Migraine | 01/25 | 01/25 | | |
| Recruiting | 3 | 1000 | Europe, Japan, US, RoW | Lasmiditan, LY573144 | Eli Lilly and Company | Migraine | 03/26 | 03/26 | | |
NusiMFM, NCT04602195: Responsiveness and Validation Study of MFM-32 in SMA Patients Treated With Nusinersen |
|
|
| Completed | N/A | 33 | Europe | | Hospices Civils de Lyon | Spinal Muscular Atrophy | 11/23 | 11/23 | | |
OPALE, NCT03058185: Observatoire Des Patients Atteints de Laminopathies et Emerinopathies (Observatory for PAtients With Laminopathies and Emerinopathies) |
|
|
| Recruiting | N/A | 800 | Europe | | Pitié-Salpêtrière Hospital, Institute of Myology, Assistance Publique - Hôpitaux de Paris, Institut National de la Santé Et de la Recherche Médicale, France | Laminopathies, Emerinopathies | 07/33 | 07/33 | | |
OTOEMHF, NCT05624983: Exploration of High Frequency Otoacoustic Emissions and Developmental Language Disorders |
|
|
| Not yet recruiting | N/A | 138 | Europe | acoustic otoemisions, Otoscopy, Audiometry, Tympanometry | University Hospital, Clermont-Ferrand | Language Development Disorders | 07/27 | 07/27 | | |
| Not yet recruiting | N/A | 20 | Europe | non interventional study | University Hospital, Brest | MECP2-Related Severe Neonatal Encephalopathy, Dysautonomia, Masculinity | 01/21 | 01/21 | | |
| Not yet recruiting | N/A | 40 | Europe | | Hospices Civils de Lyon | Spinal Muscular Atrophy | 03/21 | 03/21 | | |
| Enrolling by invitation | N/A | 20 | Europe | | University Hospital, Clermont-Ferrand | Neuroaxonal Dystrophy, Atypical | 11/22 | 12/22 | | |
ELMALEH-BERGES, Monique |
| Recruiting | N/A | 30 | Europe | sequence MRI 3D FLAIR | Fondation Ophtalmologique Adolphe de Rothschild | Endolymphatic Hydrops | 12/24 | 09/25 | | |